W
AZN icon

WealthCollab’s AstraZeneca AZN Stock Holding History

WealthCollab’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.4K Sell
88
-2
-2% -$386 0.01% 405
2025
Q4 		$16.5K Hold
90
– – 0.01% 439
2025
Q3 		$13.7K Hold
90
– – 0.01% 443
2025
Q2 		$12.5K Hold
90
– – 0.01% 443
2025
Q1 		$13.2K Buy
90
+5
+6% +$723 0.01% 402
2024
Q4 		$11.1K Buy
85
+78
+1,114% +$10.9K 0.01% 420
2024
Q3 		$1.01K Hold
7
– – ﹤0.01% 833
2024
Q2 		$1.01K Hold
7
– – ﹤0.01% 809
2024
Q1 		$881 Sell
7
-3
-30% -$397 ﹤0.01% 825
2023
Q4 		$1.28K Buy
+10
New +$1.3K ﹤0.01% 797

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

WealthCollab's AZN Position: Q1 2026 in Review

WealthCollab reduced its AstraZeneca (AZN) stake by 2.2% in Q1 2026, selling an estimated $386 and leaving 88 shares worth $17.4K. The position accounts for 0.01% of the portfolio, ranked #405.

WealthCollab first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • WealthCollab held 88 shares of AstraZeneca worth $17.4K as of Q1 2026.
  • WealthCollab sold 2 AstraZeneca shares in Q1 2026, an estimated $386.
  • AstraZeneca made up 0.01% of WealthCollab's portfolio in Q1 2026, its #405 holding.
  • WealthCollab first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.